Daiwa Securities Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-315
Closed -$7K 1415
2025
Q4
$7K Hold
315
﹤0.01% 1212
2025
Q3
$6K Sell
315
-35,000
-99% -$624K ﹤0.01% 1191
2025
Q2
$603K Buy
35,315
+33,168
+1,545% +$1.42M ﹤0.01% 823
2025
Q1
$137K Hold
2,147
﹤0.01% 963
2024
Q4
$261K Sell
2,147
-1,782
-45% -$218K ﹤0.01% 922
2024
Q3
$490K Buy
3,929
+475
+14% +$65.7K ﹤0.01% 834
2024
Q2
$546K Buy
3,454
+771
+29% +$99K ﹤0.01% 813
2024
Q1
$348K Sell
2,683
-29
-1% -$3.55K ﹤0.01% 895
2023
Q4
$262K Sell
2,712
-91
-3% -$8.73K ﹤0.01% 910
2023
Q3
$340K Buy
2,803
+556
+25% +$62.8K ﹤0.01% 885
2023
Q2
$257K Buy
2,247
+140
+7% +$18.1K ﹤0.01% 916
2023
Q1
$291K Sell
2,107
-1,242
-37% -$161K ﹤0.01% 887
2022
Q4
$434K Buy
3,349
+39
+1% +$4.52K ﹤0.01% 840
2022
Q3
$366K Sell
3,310
-81
-2% -$8.16K ﹤0.01% 864
2022
Q2
$254K Sell
3,391
-248
-7% -$18.2K ﹤0.01% 940
2022
Q1
$284K Sell
3,639
-27
-0.7% -$2.07K ﹤0.01% 942
2021
Q4
$330K Sell
3,666
-467
-11% -$39.9K ﹤0.01% 929
2021
Q3
$382K Buy
4,133
+141
+4% +$10.9K ﹤0.01% 890
2021
Q2
$310K Sell
3,992
-2,841
-42% -$215K ﹤0.01% 897
2021
Q1
$509K Sell
6,833
-201
-3% -$18.5K ﹤0.01% 796
2020
Q4
$1.2M Sell
7,034
-842
-11% -$125K 0.01% 528
2020
Q3
$1.11M Sell
7,876
-909
-10% -$138K 0.01% 486
2020
Q2
$394K Hold
8,785
0.01% 620
2020
Q1
$860K Sell
8,785
-186
-2% -$21.3K 0.01% 517
2019
Q4
$1.16M Sell
8,971
-149
-2% -$15K 0.01% 484
2019
Q3
$686K Buy
9,120
+2,481
+37% +$293K 0.01% 604
2019
Q2
$1.01M Sell
6,639
-216
-3% -$26.3K 0.01% 489
2019
Q1
$817K Sell
6,855
-427
-6% -$54.9K 0.01% 521
2018
Q4
$795K Buy
7,282
+6,925
+1,940% +$866K 0.01% 502
2018
Q3
$58K Hold
357
﹤0.01% 963
2018
Q2
$47K Hold
357
﹤0.01% 980
2018
Q1
$26K Buy
+357
New +$23.8K ﹤0.01% 982

Other funds holding SRPT